[ Neuronetics raises $15M in Series G ]

Neuronetics  has raised $15 million in Series G funding.

Founded in 2003, Neuronetics is a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses.

The company intends to use the funds to continue to expand operations.

Funding  Series G
Founded  2003
Country  USA
City  Malvern, Pennsylvania
Founder / CEO  Chris Thatcher
Deal Size  $15M
Investors  Ascension Ventures
 Accuitive Medical Ventures
 GE Ventures
 InterWest Partners
 Industry Ventures
 Investor Growth Capital
 KBL Healthcare Ventures
 New Leaf Venture Partners
 ONSET Ventures
 Pfizer Venture Investments
 Polaris Partners
 Three Arch Partners
Previous Investors same as above except  Ascension Ventures, Industry Ventures
 Partisan Management Group
 Quaker BioVentures
 Quaker Partners